Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two awards have been announced for scientists in the WIMM.

 

oni_chowdhury

Oni Chowdhury has been awarded an NIHR clinical lectureship. This will enable Oni to incorporate the remainder of her specialist clinical training with research. She will be working on the therapeutic targeting of malignant stem cells with the Stem Cell Group in the WIMM.

648A3130

Chris Babbs has been awarded a 3 year project grant, funded by Action Medical Research for Children, to identify new alleles and genes underlying Congenital Dyserythropoietic Anaemia type I, a variable anaemia that manifests in childhood. Coding mutations in the genes previously shown to underlie this disease explain only ~60% of cases, strongly suggesting the presence of occult pathogenic alleles or the involvement of a further locus. Identification of further genetic lesions will improve molecular diagnosis and is likely to shed light on the pathogenic mechanism underlying this disorder. The defining cellular characteristic of this anaemia is abnormal chromatin formation in erythroblast nuclei, suggesting that all causative mutations affect a pathway critical for chromatin assembly or compaction in maturing erythroblasts. By introducing specific mutations into induced pluripotent stem cells we hope to shed light on the pathogenic mechanism and establish a high throughput screening system to test small molecules as potential therapy for this disorder.

Congratulations to both of them.

Similar stories

Research unpicks why immune responses decrease with age

MRC MHU

Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells

MRC MHU NDM RDM

New Nature paper reveals discovery of a genetic vulnerability in nearly 10% of breast cancer tumours and how this can be targeted to selectively kill cancer cells.

Developing a rapid and cost-effective way to identify newborns at risk of leukaemia

MRC MHU

MRC WIMM researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe.